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The biofilm physiology of pathogenic bacteria has mostly been studied in vitro using flow-chamber setups, where a continuous flow of media has maintained the external chemical microenvironment constant (1) , resulting in vertically and laterally stratified distributions of nutrients and metabolites, that is, the formation of concentration gradients, due to (i) mass transfer impedance between fluid and the exopolymeric biofilm matrix, and (ii) heterogeneity in biomass distribution (2) (3) (4) (5) . In the presence of such gradients, the bacteria can adapt their physiology according to the actual chemical microenvironment in the biofilm resulting in distinct growth zones and modes of metabolism (2) . Thus, the growth of such in vitro biofilms creates internal chemical and physiological gradients, which are largely governed by solute exchange with the medium and the diffusive properties and restricted bacterial mobility in the biofilm exopolymeric matrix. In biofilms associated with chronic infections CF patients, however, direct evidence of physiological gradients within in vivo biofilms is lacking. In fact, the finding of low and uniformly distributed growth inside biofilm aggregates of the important pathogenic bacterium Pseudomonas aeruginosa in the chronically infected lungs of cystic fibrosis (CF) patients (6) points to the absence of physiological differentiation inside such cell aggregates. In addition, the low in vivo growth rates of pathogens, the hypoxic or anoxic conditions in infected CF endobronchial mucus (7) , and the accumulation of numerous polymorphonuclear leukocytes (PMNs) around bacterial biofilm aggregates (8) imply that the majority of O 2 is not consumed by the biofilm but rather by the host immune response outside the biofilm. In particular, PMNs that accumulate around P. aeruginosa biofilms in vivo (8) can cause intense O 2 depletion during their respiratory burst (9) and the formation of nitric oxide (NO) (10) in endobronchial secretions from CF patients with chronic P. aeruginosa lung infection. This PMN-imposed restriction of O 2 availability for the pathogens in vivo is unlike most in vitro biofilm studies, where normoxic media are typically supplied continuously. In this review, we discuss current evidence for a new working model of chronic infections in CF patients, proposing that it mainly is the interaction between PMNs and P. aeruginosa biofilm aggregates that imposes physiological constraints on the in vivo biofilm, and modulates the biofilm microenvironment in CF lungs. We also discuss important implications of this revised view on infectious biofilms for the antibiotic treatment of chronic lung infections.
THE HOST IMMUNE RESPONSE CHANGES THE CHEMICAL MICROENVIRONMENT DURING CHRONIC LUNG INFECTION IN CF LUNGS
Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator gene affecting apical ion transport (11) . The defective ion transport results in the formation of thick viscous mucus, which makes the lungs susceptible to chronic respiratory infections by preventing mucociliary clearance (12, 13) and impeding solute mass transfer and penetration of antibiotics in the mucus (14) (15) (16) . Chronic lung infection is the most severe complication in CF and P. aeruginosa is the major bacterial pathogen causing such infection (17, 18) . In the chronic lung infection, P. aeruginosa exists in small biofilm cell aggregates that are persistently surrounded by PMNs in the endobronchial mucus (8, 19, 20) . According to O 2 measurements directly in the lungs of CF patients, the infected endobronchial mucus is subject to severe hypoxia or even anoxia (7) . Besides aerobic respiration by the lung epithelium (7), the depletion of O 2 is predominantly caused by host immune cells, that is, PMNs that inflict a strong local O 2 consumption for their production of superoxide (O 2 À ) (9) and to a lesser extent for production of nitric oxide (NO) (10) . The O 2 consumption by microbial aerobic respiration thus appears diminutive under such in vivo conditions in the CF lung (9) .
Accelerated O 2 consumption by activated PMNs has long been recognized (21) and is due to a oneelectron step reduction of O 2 to O 2 À (22) by a NADPH oxidase (23) named NOX-2 (24) that leads to a process known as the respiratory burst (25) . In spite of this name, PMNs are barely engaging in aerobic respiration for acquiring ATP, and <3% of provided glucose is oxidized through the TCA in PMNs (26) . The PMNs mainly produce ATP via anaerobic glycolysis (27) , and inhibition of their terminal cytochrome C oxidase neither decrease O 2 consumption nor production of O 2 À in PMNs (9, 28) . Thus, O 2 consumption by PMNs is devoted for the production of reactive oxygen species (ROS) that are essential for the antimicrobial host response; patients with defective ROS production, such as patients with chronic granulomatous disease (29) are therefore very susceptible to bacterial and fungal infections (30) .
Most infectious biofilms are characterized by a stimulation of an inflammatory response that is typically dominated by PMNs (31) . Increased ROS production and thus O 2 consumption by PMNs is a stereotypical response that can be activated by both fungal intruders, Gram-positive and Gram-negative planktonic bacteria (9, 32) , by bacterial biofilms (33) , as well as by sterile tissue damage (34) . Therefore, a variety of stimuli can strongly affect the O 2 availability for infectious microbial biofilms and consequently, we propose that O 2 depletion in infected endobronchial CF mucus is primarily due to O 2 consumption by activated PMNs. Sputum samples from CF patients with P. aeruginosa chronic lung infection generally contain PMNs with ongoing respiratory burst (9, 35) and NO production (10) . In accordance, sputum samples from adult CF patients with P. aeruginosa chronic lung infection exhibit steep O 2 concentration gradients and very thin oxygenated surface zones (36) . Similar O 2 gradients have also been measured in fresh sputum from pediatric CF patients with lung infections involving various bacterial species (37) . During biofilm infections, activated PMNs may thus expand the O 2 -depleted zones in the lung to an extent that favors pathogenic adaptation to anaerobic physiology and such an adaptation has actually been confirmed in vivo by several biomarkers (see below).
Activated PMNs may also decrease extracellular pH (38, 39) and secrete lactate (40) , and acidic conditions of pH < 6.2 have been measured in endobronchial mucus (41) and in freshly expectorated sputum from CF patients with lung infection (37) . Additional host responses also affect the availability of potential alternative electron acceptors for anaerobic microbial metabolism. In CF sputum, high levels of nitrate (NO 3 À ) and nitrite (NO 2 À ) of~0.05-1 mM have been measured (36, (42) (43) (44) , and increased levels of NO 3 À and NO 2 À in the blood have also been observed during experimental P. aeruginosa lung infection (45) that may be linked to the host response. Activated PMNs in infected CF sputum have thus been shown to liberate NO 3 À and NO 2 À (46) probably resulting from the degradation of peroxynitrite generated from the rapid reaction between O 2 À and NO produced by activated NOX-2 and nitric oxide synthase (47, 48) .
Growth and biofilm structure
In vitro biofilms grown in flow cells and drip-flow reactors exhibit formation of step chemical gradients (2, 49) . These result in heterogeneous growth patterns forming a complex structural and chemical landscape (3) (4) (5) 49) . In such in vitro biofilms, bacterial growth rate has been estimated to rapidly drop with distance from the biofilm surface reaching quasi-static growth at 40-50 lm depth (49, 50) . As illustrated in Fig. 1 , such a decline in aerobic growth can be attributed to electron acceptor limitation due to rapid in vitro O 2 depletion by bacterial biomass coupled with mass transfer limitation of the diffusive O 2 supply from the surrounding medium (3, 4, 51, 52) .
However, we note that the presence of large surface-attached biofilms with pronounced intrabiofilm gradients as seen in vitro remain to be demonstrated in chronic biofilm infections of CF lungs. In vivo biofilms in most chronic infections are typically found as small, suspended small cell aggregates that are surrounded by a high concentration of PMNs (6, 19) . A meta-analysis of the size of such biofilm aggregates in various chronic infections showed a biofilm aggregate diameter range of 4-200 lm with a median diameter of 50 lm in chronic CF lung infections, chronic wounds, and implant-associated and Otitis media infections (19) (Fig. 2) . These in vivo biofilm dimensions are thus in strong contrast to large area surface-attached in vitro biofilms typically ranging from~50 lm to several hundred micrometers in thickness (53, 54) .
Growth rates of P. aeruginosa within different biofilm aggregates in lung tissue from chronically infected CF patients showed significant variability among individual aggregates throughout the lungs (6). However, growth across individual biofilm aggregates, that is, a comparison of growth rates of bacteria in the periphery and more central parts of individual aggregates, showed no significant differences (6) . Thus, the heterogeneous growth patterns driven by chemical gradients in biofilms grown in vitro could not be demonstrated in vivo in biofilm aggregates characteristic of chronic CF lung infection. Instead, in vivo growth rate heterogeneity between individual biofilm aggregates showed a statistically significant correlation with the local concentration of PMNs surrounding the bacterial biofilm aggregates, where a higher concentration of PMNs lead to slower growth within the biofilms (6) . High consumption of O 2 by the PMNs can thus have a bacteriostatic effect on cells within the biofilms as a whole. In this way, the surrounding inflammation can be viewed as a secondary matrix through which chemical gradients may build toward the periphery of the biofilm and not through the biofilm itself (6) . Several studies have investigated the growth pattern of bacteria in the lungs of patients with CF. It is interesting that these studies have shown that species frequently classified as obligate aerobes, such as Staphylococcus aureus, Stenotrophomonas maltophilia, and Achromobacter xylosoxidans, exhibit virtually zero growth, which is in line with depletion of O 2 in infected parts of the CFs lungs, whereas the facultative anaerobe P. aeruginosa exhibits slow growth under these conditions (6, (55) (56) (57) (58) . We conclude that PMNs apparently play a major role in modifying the chemical microenvironment thereby imposing growth restriction upon pathogens in biofilm aggregates associated with chronic lung infections of CF patients. As susceptibility to several types of antibiotics may be decreased by low availability of O 2 (59-61) and slow growth (62) (63) (64) (65) (66) , PMNs may also play a major role in rendering in vivo biofilms resistant to antibiotics (Fig. 1E,F; Fig. 3 ). In the following, we discuss how P. aeruginosa may operate and adapt to biofilm life in an ecological niche in CF lungs, where O 2 is largely absent due to PMN activity.
Metabolic flexibility in P. aeruginosa
The ability of microorganisms to exploit a wide range of electron acceptors for ATP generation provides metabolic flexibility in transient environments enabling the population of a variety of terrestrial and aquatic habitats (67) . Such metabolic flexibility may also be an important trait in pathogens causing chronic infections. The opportunistic pathogen P. aeruginosa can grow under anoxic conditions by denitrification (68) or arginine fermentation (69, 70) , while anaerobic pyruvate fermentation can support long-term survival of P. aeruginosa, but does not enable growth (71) . The intensive depletion of O 2 caused by activated PMNs in infected endobronchial secretions (9) may thus impose a necessary shift from aerobic to anaerobic lifestyles of microorganisms in biofilm aggregates. Accordingly, anoxic zones in freshly expectorated sputum from CF patients with P. aeruginosa lung infections exhibit production of nitrous oxide (N 2 O) (Fig. 4) (36, 37) , which is a signature of denitrification (68 
The CF pathogens, P. aeruginosa, A. xylosoxidans, B. multivorans, and S. maltophilia, all exhibit biofilm growth associated with chronic lung infections (74) (75) (76) . During anoxia, clinical isolates of these four pathogens responded to supplemental NO 3 À by increased growth and were apparently capable of NO 3 À depletion, while only P. aeruginosa and A. xylosoxidans displayed the formation of N 2 O (56). The genetic set-up for complete denitrification from NO 3 À to N 2 is found in P. aeruginosa (77, 78) as well as in A. xylosoxidans (78). However, formation of N 2 from NO 3 À via denitrification has so far only been demonstrated in cultures of P. aeruginosa (68) and remains to be firmly verified in cultures of A. xylosoxidans.
RESPONSE OF P. AERUGINOSA TO HYPOXIA
Aerobic respiration in P. aeruginosa involves a four-electron reduction of O 2 to H 2 O via five terminal oxidases (79) (80) (81) (82) (83) (84) . The cbb 3 -1 oxidase, the ccb 3 -2 oxidase, and the aa 3 oxidase are all cytochrome c oxidases, while the bo 3 oxidase and the cyanideinsensitive oxidase (CIO) are quinol oxidases. Each oxidase has a specific affinity for O 2 , efficiency of proton translocation, and tolerance to stress imposed by, for example, reactive nitrogen species and cyanide (85) . While the cbb 3 are oxidases with high affinity for O 2 (86) the aa 3 , bo 3, and CIO oxidases have low affinity to O 2 (85) (86) (87) .
The four reductase enzymes involved in denitrification are induced by low O 2 tension and the presence of NO 3 À (88). The anaerobic regulator of arginine and nitrate reductase (Anr) (belonging to the Fnr-Crp regulator family) is on top of the regulatory network controlling the activity of the four central denitrification enzymes and thereby anaerobic energy metabolism (89) (90) (91) (92) . However, the additional transcriptional regulators Dnr and NarX-NarL are also needed for denitrification. NarX detects NO 3 À and activates NarL, that downregulates arginine fermentation (93) (94) (95) , while Dnr is highly dependent on the activation of Anr to activate the cascade of genes encoding the Nar, Nir, Nor, and Nos reductases (94) . In addition, Dnr responds to the presence of NO (96) (97) (98) . Furthermore, the P. aeruginosa quorum-sensing regulator, RhlR, can repress the expression of the four reductase-coding genes (99) together with the quinolone signal (PQS) (100) .
The Anr regulator is also a main regulatory factor controlling the five terminal oxidases involved in aerobic respiration by P. aeruginosa as it monitors the O 2 concentration, and at low O 2 concentrations activates the expression of the cbb 3 -1 and the ccb 3 -2 oxidase as well as represses the expression of CIO (85) . Regulation of aa3 and bo3 appears to depend on nutrient and iron starvation (85) .
Even though the citric acid cycle is fully operative in bacteria under denitrifying conditions, (101) more energy is preserved during aerobic respiration (102) . Recently, the NOx reductases has been proposed to contribute to the proton motive force by only six protons per 2 electrons from one molecule of NADH, and considering that half of the generated ATP during denitrification is available for growth, this suggests that the growth yield per oxidized NADH by denitrification is only 30% of the growth yield during aerobic respiration (102) . Accordingly, the growth of P. aeruginosa is expected to be lower with nitrogen oxides as electron acceptors than under aerobic conditions, and the observation of slow growth in P. aeruginosa biofilm in the lungs (6) along with the N 2 O formation in expectorated sputum supports the hypothesis that denitrification is an important metabolic pathway for P. aeruginosa biofilms during lung infection in CF patients.
BACTERIAL RESPONSE TO O 2 DEPLETION DURING CHRONIC CF LUNG INFECTION
First evidence for anaerobic growth of P. aeruginosa in CF lungs was provided by the demonstration of O 2 depletion and the presence of OprF, a biomarker of denitrification in the endobronchial mucus from chronically infected CF patients (7, 103) . Denitrification by P. aeruginosa has been further confirmed by the production of N 2 O in anoxic parts of sputum samples from CF patients with chronic P. aeruginosa lung infection (35), (Fig. 4) . The absence of O 2 in parts of the CF airways has been further confirmed by the isolation of obligate anaerobes from CF sputum and bronchoalveolar lavage fluids (104) , by the demonstration of anoxic zones in CF sinuses (105) , as well as by the presence of anoxic zones in CF sputum (35, 36) . Several other biomarkers of P. aeruginosa engaged in anaerobiosis during chronic lung infection in CF have been isolated from sputum. These include, antibodies against OprF and Nar in sera (103, 106) , the upregulation of the denitrification reductases in CF sputum (107) and CF isolates (108, 109) , and the increased transcription of the anaerobic regulator gene anr and upregulation of Anr-dependent genes (108) . Additionally, after antimicrobial treatment the infected sputum content of NO 3 À increases (41) indicating a reduction in the activity of denitrifying cells.
The effect of anaerobiosis on the pathogenicity of P. aeruginosa may be highly relevant since production of the viscous matrix component alginate is increased when O 2 is absent (7, 110) . Alginate is linked with decreased lung function (111), possibly due to the ability of alginate to provide protection against antibiotics (112, 113) and phagocytic killing (114) . Additionally, components of the anaerobic respiration pathway are immunogenic as evidenced by the presence in sera of antibodies against OprF and Nar (103, 106) , and the activity of the nitrite reductase is required for type III secretion resulting in prolonged survival in human monocytes (115) and enhanced virulence (116) . Moreover, the N 2 O production in infected CF sputum (35) indicates that NOR is active in P. aeruginosa, which is associated with higher tolerance against NO produced by macrophages (117) and has been shown to cause increased virulence during infection in silkworms (118) .
In CF patients with chronic P. aeruginosa lung infection, the existence of pulmonary niches with low O 2 levels has been demonstrated directly in the bronchial mucus (7) and in sputum samples (35, 36) , and evidence for growth in such niches comes from the observation of the increased expression of genes involved in microaerobic respiration such as the high-affinity oxidase cbb3 (108) . Furthermore, P. aeruginosa CF PAO1 cultures kept at O 2 levels resembling the hypoxic pulmonary niches exhibit slow growth corresponding to in vivo pulmonary growth rates of P. aeruginosa reported in CF lungs (6, 87) .
EFFECTS OF THE CHEMICAL MICROENVIRONMENT ON BACTERIAL SUSCEPTIBILITY TO ANTIMICROBIALS
Most studies of antimicrobial tolerance have not focused on the hypoxic or anoxic conditions experienced in vivo by P. aeruginosa in their biofilm micro-niche surrounded by PMNs in the chronically infected CF lung. Yet, tolerance toward antibiotics in biofilms is recognized as a major cause of therapeutic failure during chronic infection and the mechanisms of antimicrobial tolerance in vivo are not completely understood (119) .
Physiological stratification in biofilms grown in vitro confers tolerance to several commonly used antibiotics due to limited O 2 availability and nutrient supply to deeper biofilm layers (120, 121) . Several bactericidal antibiotics such as ciprofloxacin target aerobic respiration and induce lethal cellular damage by redox-related physiological modifications resulting in formation of ROS (60, 61, (122) (123) (124) . In fact, several common types of antibiotics such as aminoglycosides, beta-lactams and quinolones target processes linked to the TCA cycle in metabolically active bacteria leading to the formation of toxic ROS that contribute to the bactericidal activity of the antibiotic during aerobic respiration (60, 122) . Accordingly, the bactericidal activity of ciprofloxacin and tobramycin was decreased when the availability of O 2 was reduced (59, 60) . The slow growth associated with low levels of O 2 (87) may also contribute to tolerance against tobramycin and ciprofloxacin in biofilm as well as in planktonic cultures (62, 63, 64) .
To overcome antibiotic tolerance in biofilms, alleviation of O 2 limitation may activate aerobic respiration and thus increase the susceptibility of pathogens to several antibiotics targeting metabolically active bacteria. As an example, hyperbaric O 2 treatment (HBOT) may significantly enhance the efficacy of antibiotic treatment in vitro (125) (126) (127) and HBOT has the potential to enhance the antibiotic activity during experimental in vivo biofilm infections (128) (129) (130) . Enhanced antibiotic activity against in vitro biofilm may also be achieved by supplying pure O 2 at normobarric levels (131) .
In contrast, the bactericidal activity of colistin on P. aeruginosa does not require the formation of toxic levels of ROS from O 2 (60) , and the bactericidal activity of colistin is actually enhanced in the absence of O 2 (132) . The bactericidal activity of colistin mainly depends on its interaction with lipopolysaccharides (LPSs) within the outer bacterial membrane (133, 134) . Decreased tolerance of anaerobic biofilm against colistin may thus be due to limited ability to establish tolerance by actively modifying LPS (135) (136) (137) due to the reduced production of ATP during anaerobic respiration as discussed above. A better understanding of the effects of anoxia and re-oxygenation on the susceptibility of biofilms to various antimicrobials may facilitate optimized selection of antimicrobials against biofilm during chronic infections. There is thus a strong need for further studies focusing on relating the in vivo susceptibility of biofilms to antibiotics to the chemical microenvironment in chronic infections, and how it is shaped by the host immune response.
CHEMICAL MICROENVIRONMENT DURING BIOFILM INFECTION IN NON-CF PATIENTS
Albeit this review focuses on how immune responses change the growth landscape for pathogenic bacteria causing chronic lung infections in CF patients, we also advocate that similar effects could be relevant in other chronic infections. The involvement of bacterial biofilms in the poor healing of chronic wounds has lately received increased attention (138, 139) , and it has been demonstrated in experimental wounds that infection with P. aeruginosa biofilms impairs wound closure rates (140, 141) . It was also shown that steep O 2 gradients are present in the wound scab of diabetic mice with P. aeruginosa biofilm infection in their dorsal wound (142) . Such hypoxic conditions may contribute significantly to delayed wound healing (143) (144) (145) . The source of O 2 depletion in infected wounds is far from clarified, but the finding of enhanced expression of bacterial genes associated with O 2 limitation and anaerobic growth in infected wounds of diabetic mice (142) indicate a significant consumption of O 2 outside the biofilm. Increased accumulation of PMNs in human and mouse wounds with biofilm infection (146, 147 ) also indicate that PMNs may dominate local O 2 consumption around bacterial aggregates in wounds similar to patterns observed in the infected CF lung, but this proposal awaits further experimental investigation.
CONCLUSION AND OUTLOOK
In vitro studies of P. aeruginosa and other pathogenic bacteria have yielded detailed insight to their potential growth modes and metabolic flexibility when switching between planktonic and biofilm habitats, and under exposure to gradients of substrate and electron acceptor. However, in chronic lung infections of CF patients, the growth pattern of P. aeruginosa is very different from what is observed in vitro. Dense in vitro biofilms of P. aeruginosa exhibit rapid O 2 depletion within <50-100 lm due to their own aerobic metabolism. In contrast, in vivo investigations show that P. aeruginosa persists in the chronically infected CF lung as relatively small cell aggregates that are surrounded by many PMNs, where the activity of PMNs is the major cause of O 2 depletion rendering the P. aeruginosa aggregates anoxic. High levels of nitrate and nitrite enable P. aeruginosa to persist fueled by denitrification in the PMN-surrounded biofilm aggregates. This configuration creates a potentially long-term stable ecological niche for P. aeruginosa in the CF lung, which is largely governed by slow growth and anaerobic metabolism and enables persistence and resilience of this pathogen even under the recurring aggressive antimicrobial treatments of CF patients. There is now a clear need for better in vitro models that simulate such in vivo growth patterns and anoxic microenvironments and that can help unravel, for example, the efficiency of existing or new antimicrobials targeting anaerobic metabolism in P. aeruginosa. Host immune responses such as PMN-driven O 2 depletion may also play a central role in the formation of anoxic microniches governing bacterial persistence in other chronic infections such as chronic wounds. 
